ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Psychiatry

Top Psychiatry Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL PATNAUDE DO

Psychiatry

1,332

$152K

93
23 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 25%

$114
Average prescription price

Avg: $107

PAMELA BOKAT MD MSW

Psychiatry

1,325

$162K

146
12 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$122
Average prescription price

Avg: $107

RICHARD NILSON M.D.

Psychiatry

1,320

$131K

130
24 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$99
Average prescription price

Avg: $107

DINAH TUNGOL M.D.

Psychiatry

1,270

$145K

69
0 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$114
Average prescription price

Avg: $107

EVE WOLINSKY MD

Psychiatry

1,252

$138K

101
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$110
Average prescription price

Avg: $107

PONGSAK HUANGTHAISONG MD

Psychiatry

1,207

$162K

99
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$134
Average prescription price

Avg: $107

THOMAS RUSK MD

Psychiatry

1,170

$138K

102
0 are 65+

50%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $107

MICHAEL GARNETT MD

Psychiatry

1,124

$117K

99
19 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$104
Average prescription price

Avg: $107

SALLY WEISS MD

Psychiatry

1,052

$92.6K

68
32 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 25%

$88
Average prescription price

Avg: $107

BARBARA REEVE M.D.

Psychiatry

1,051

$135K

49
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $107

JOSEPH RUBIN MD

Psychiatry

1,047

$108K

65
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$103
Average prescription price

Avg: $107

NIAMH HOLOHAN MD

Psychiatry

1,001

$148K

60
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$148
Average prescription price

Avg: $107

RICHARD FORTIER

Psychiatry

999

$87.2K

79
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$87
Average prescription price

Avg: $107

MARIE GUAY DO

Psychiatry

977

$76.4K

67
33 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $107

MIMI ARMELLINO DO

Psychiatry

969

$81.3K

62
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $107

MARK JENSEN D.O.

Psychiatry

917

$72.6K

323
278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $107

MICHAEL TOFANI MD

Psychiatry

877

$87.6K

142
40 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$100
Average prescription price

Avg: $107

CHARLES MITCHELL MD

Psychiatry

875

$123K

56
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 25%

$140
Average prescription price

Avg: $107

CHRISTINE WHITE M.D.

Psychiatry

873

$82.5K

51
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$95
Average prescription price

Avg: $107

DAVID NAGLER MD

Psychiatry

861

$93.7K

55
23 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$109
Average prescription price

Avg: $107

EDWARD BILOTTI MD

Psychiatry

856

$95.3K

118
19 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$111
Average prescription price

Avg: $107

IRA SHAPIRO MD

Psychiatry

839

$44K

33
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $107

DAVID JONES D.O.

Psychiatry

831

$123K

94
23 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$149
Average prescription price

Avg: $107

SILVIO SAIDEMBERG M.D.

Psychiatry

787

$69.1K

73
18 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$88
Average prescription price

Avg: $107

MILES SIMMONS MD

Psychiatry

776

$65.9K

39
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $107

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank